Skip to content

OS Therapies OSTX Reimbursable Grant Amount

Reimbursable Grant Amount at other companies

Novavax logo
NovavaxNVAX
$27.72M+146%
ATN International logo
ATN InternationalATNI
$17.77M-37.4%
Evommune
 logo
Evommune EVMN
$104.99K
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$1.36M+33.7%
Blink Charging Co. logo
Blink Charging Co.BLNK
$722K
Nano Nuclear Energy logo
Nano Nuclear EnergyNNE
$15K

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept osti:ReimbursableGrantAmount.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's reimbursable grant amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's reimbursable grant amount?
OS Therapies (OSTX) reported reimbursable grant amount of $100K in Q4 2021.
What does reimbursable grant amount mean?
The total value of research or operational expenses eligible for reimbursement through government or private grants. This metric indicates the company's ability to offset development costs through non-dilutive funding sources.